Press Release: Amplitude Surgical Announces Its 2024-25 Financial Calendar

Dow Jones11-21

Amplitude Surgical Announces Its 2024-25 Financial Calendar 

VALENCE, France--(BUSINESS WIRE)--November 20, 2024--

Regulatory News:

Amplitude Surgical (ISIN: FR0012789667, Mnemo: AMPLI, PEA-PME eligible), the French market leader in surgical technologies for lower limb orthopedics, announces its financial agenda for the 2024-25 financial year. 

 
         Events                        Dates * 
-------------------------    --------------------------- 
2024-25 Q1 Sales             Thursday, November 21, 2024 
-------------------------    --------------------------- 
2024-25 H1 Sales             Thursday, February 20, 2025 
-------------------------    --------------------------- 
2024-25 H1 Results           Wednesday, March 26, 2025 
-------------------------    --------------------------- 
2024-25 Q3 Sales             Thursday, April 17, 2025 
-------------------------    --------------------------- 
2024-25 Full-year Sales      Thursday, July 24, 2025 
-------------------------    --------------------------- 
2024-25 Full-Year results    Wednesday, October 22, 2025 
-------------------------    --------------------------- 
2025-26 Q1 Sales             Thursday, November 20, 2025 
-------------------------    ---------------------------

* Subject to change. Press releases are published after market close.

Next press release:

2024-25 Q1 Sales: Thursday, November 21, 2024, after market close.

About Amplitude Surgical

Founded in 1997 in Valence, France, Amplitude Surgical is a leading French player in the global market for orthopedic surgical technologies for the lower limbs. Amplitude Surgical develops and markets high-end products for orthopedic surgery, covering the main pathologies affecting the hip and knee. Working in close collaboration with surgeons, Amplitude Surgical develops numerous high value-added innovations to meet the needs of patients, surgeons and care facilities. A leading player in France, Amplitude Surgical is expanding internationally through its subsidiaries and a network of agents and exclusive distributors in over 30 countries. At June 30, 2024, Amplitude Surgical employed 428 people and generated sales of nearly 106.0 million euros.

View source version on businesswire.com: https://www.businesswire.com/news/home/20241120898119/en/ 

 
    CONTACT:    Amplitude Surgical

Chief Financial Officer

Dimitri Borchtch

finances@amplitude-surgical.com

04 75 41 87 41

NewCap

Investor Relations

Thomas Grojean

amplitude@newcap.eu

01 44 71 94 94

NewCap

Media Relations

Nicolas Merigeau

amplitude@newcap.eu

01 44 71 94 98

(END) Dow Jones Newswires

November 20, 2024 12:00 ET (17:00 GMT)

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment